Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
  • Toggle search form
  • [Research] Samsung SDI (006400/KS) – SK Securities | Prominent Base Effects · Conservative CapEx Management · Compelling Valuation / 2026-02-03 Research
  • [Research] Samsung Biologics (207940) – IBK Securities | US Operations · Plant 5 Ramp-up · Peptide Expansion / 2026-07-24 Research
  • [Research] Samsung SDI (006400) – Hana Securities | North America JV Resolution · ESS Line Conversion · Earnings Estimate Upgrades / 2026-08-12 Research
  • [IR] SK hynix (000660 / SKHY) – Q1 2026 Earnings Presentation / 2026-04-23 IR Room
  • [Research] SK hynix (000660 / SKHY) – Kiwoom | Commodity Memory Pricing · Supply Constraints · Earnings Surge / 2026-05-11 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | LTA · HBM Demand · Valuation Re-rating / 2026-05-27 Research
  • [Research] SK hynix (000660 / SKHY) – Kiwoom | Server DRAM · eSSD · Earnings Upgrades / 2026-04-09 Research
  • [Research] LIG D&A (079550) – iM Securities | Export Pipeline · CapEx & Hiring Expansion · Global Air Defense Growth / 2026-08-07 Research

[Research] SK hynix (000660 / SKHY) – SK Securities | LTA · Capex Discipline · Cycle Stability / 2026-01-28

Posted on January 28, 2026August 24, 2026 By ksb220805@gmail.com

Market: KOSPI (000660)

Brokerage : SK Securities

Analyst : Donghee Han

Investment Rating : BUY (Maintained)

Target Price : 1,500,000 KRW (Raised)

Core Momentum : An LTA-driven order-first supply structure combined with disciplined capacity expansion is expected to prolong memory shortages and reduce traditional cycle volatility, supporting record profitability and structurally higher earnings visibility.

📊 1. [Valuation & Key Financial Metrics]

  • Target Price: 1,500,000 KRW (Based on Target P/E 9.0X applied to 2026E EPS of 160,368 KRW, 50% Raised)
  • Investment Rating: BUY (Maintained)
  • 2026E Financial Outlook: Revenue 205.15 trillion KRW, Operating Profit 147.22 trillion KRW, Net Income 116.75 trillion KRW
  • EPS: 160,368 KRW (2026E)
  • Valuation Multiples: PER 5.0x, PBR 2.5x, EV/EBITDA 2.8x, ROE 67.4% (Based on 2026E)

🚀 2. [Market Opportunities & Business Outlook]

  • Upgraded Industry Projections: Reflecting stronger-than-expected memory market conditions, 2026E memory price increase forecasts are revised upward to +71% for DRAM and +83% for NAND.
  • Earnings Outlook: Operating profit for 2026 is projected to reach 147 trillion KRW (+213% YoY) with an operating margin of 72%, setting all-time highs in both earnings and profitability, exceeding market consensus operating profit by 34%.
  • Structural Shift: The memory industry is transitioning into an “order-first, expansion-later” structure anchored by long-term contracts (LTAs), breaking away from traditional cyclicality. Amid sustained CapEx discipline and space constraints, supply shortages are compounding across all product lines including HBM3E/4, generic DRAM, and SSDs.
  • Cash Flow Deployment: Accumulated robust cash flows will be utilized for shareholder returns, contract-based facility investments, and M&As to enhance corporate value.

📝 Editor’s Comment (Perspective)

The analyst views SK hynix as transcending traditional cyclical limitations through an LTA-anchored “order-first, expansion-later” framework, supported by ongoing CapEx discipline and spatial constraints. The analyst emphasizes that peak-out concerns are merely cyclical rhetoric, and attention should instead focus on valuation expansion propelled by supply constraints and strong cash generation.

To verify this investment thesis, one should track whether actual 2026 memory price increases meet the revised projections (DRAM +71%, NAND +83%), if optimized LTA weightings and supply structures translate into stable earnings growth, and how cumulative cash flows effectively result in enhanced shareholder returns and corporate value-up initiatives. These indicators can be monitored through upcoming quarterly reports and regulatory filings via DART.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, Semiconductors

Post navigation

Previous Post: [Research] LigaChem Biosciences (141080) – Mirae Asset Securities | Clinical Readouts · Pipeline Valuation · SOTP / 2026-01-26
Next Post: [IR] SK hynix (000660 / SKHY) – Q4 2025 Earnings Presentation / 2026-01-29

Related Posts

  • [Research] Celltrion (068270) – Yuanta Securities | New Biosimilar Growth · Facility Expansion · CMO Capacity Readiness / 2026-05-07 Research
  • [Research] Alteogen (196170) – Hana Securities | Target Price Adjusted on Royalty Structure & Deal Assumptions · Deal Acceleration Starts in 2026 / 2026-01-22 Research
  • [Research] Samsung SDI (006400) – Shinhan Securities | Expanding North American ESS Momentum · Sole Non-China Prismatic Maker · 4Q In Line / 2026-02-03 Research
  • [Research] SK hynix (000660 / SKHY) – iM Securities | Fixed Memory Pricing · Supply Shortage · Earnings Growth / 2026-01-30 Research
  • [Research] Samsung SDI (006400) – iM Securities | ESS Business Pivot · AMPC Benefits · Earnings Visibility / 2026-07-31 Research
  • [Research] Samsung SDI (006400) – Hana Securities | Plant Utilization Recovery · North America ESS Demand · Valuation Re-rating / 2026-04-29 Research
  • [Research] Samsung SDI (006400) – IBK Securities | ESS Shipment Expansion · AMPC Benefits · Profit Turnaround / 2026-07-31 Research
  • [Research] Samsung Electro-Mechanics (009150) – IBK Securities | MLCC Price Hike · Supply Shortage · Earnings Acceleration / 2026-07-31 Research
  • [Research] Samsung SDI (006400) – Mirae Asset | Operating Profit Upgrades · Core Turnaround · Prismatic Competitiveness / 2026-07-31 Research
  • [Research] SK hynix (000660 / SKHY) – Hana | Commodity DRAM Pricing · LTA · Multiple Expansion / 2026-06-26 Research
  • [Research] Samsung SDI (006400) – Hana Securities | Plant Utilization Recovery · North America ESS Demand · Valuation Re-rating / 2026-04-29 Research
  • [Research] Samsung Biologics (207940) – Kiwoom Securities | Plant 6 Groundbreaking Visibility · Labor Negotiation · Rockville Revenue Recognition / 2026-04-02 Research
  • [Research] Samsung Biologics (207940) – DS Investment & Securities | Plant 5 Revenue Contribution · US Plant Acquisition · Plant 6 Groundbreaking / 2026-04-23 Research
  • [Research] LIG D&A (079550) – Hana Securities | 4Q25 Miss · Solid Order Backlog · Medium-to-Long-term Fundamentals / 2026-02-19 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme